NO914968L - Benzodiazepinoner - Google Patents

Benzodiazepinoner

Info

Publication number
NO914968L
NO914968L NO91914968A NO914968A NO914968L NO 914968 L NO914968 L NO 914968L NO 91914968 A NO91914968 A NO 91914968A NO 914968 A NO914968 A NO 914968A NO 914968 L NO914968 L NO 914968L
Authority
NO
Norway
Prior art keywords
benzodiazepinones
Prior art date
Application number
NO91914968A
Other languages
English (en)
Norwegian (no)
Other versions
NO914968D0 (no
Inventor
Ming-Chu Hsu
Donna Mary Huryn
Steve Yik-Kai Tam
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO914968D0 publication Critical patent/NO914968D0/no
Publication of NO914968L publication Critical patent/NO914968L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91914968A 1990-12-17 1991-12-16 Benzodiazepinoner NO914968L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62855190A 1990-12-17 1990-12-17

Publications (2)

Publication Number Publication Date
NO914968D0 NO914968D0 (no) 1991-12-16
NO914968L true NO914968L (no) 1992-06-18

Family

ID=24519378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914968A NO914968L (no) 1990-12-17 1991-12-16 Benzodiazepinoner

Country Status (18)

Country Link
EP (1) EP0491218A1 (xx)
JP (1) JPH04275287A (xx)
KR (1) KR920012070A (xx)
CN (1) CN1062528A (xx)
AU (1) AU8974191A (xx)
BR (1) BR9105406A (xx)
CA (1) CA2057646A1 (xx)
CS (1) CS381891A3 (xx)
FI (1) FI915915A (xx)
HU (1) HUT59920A (xx)
IE (1) IE914369A1 (xx)
IL (1) IL100364A0 (xx)
IS (1) IS3792A7 (xx)
MX (1) MX9102580A (xx)
NO (1) NO914968L (xx)
PT (1) PT99821A (xx)
YU (1) YU194691A (xx)
ZA (1) ZA919850B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221687B (xx) * 1992-01-24 1994-03-11 Hoffmann La Roche
JPH06501502A (ja) * 1992-02-26 1994-02-17 エフ・ホフマン−ラ ロシユ アーゲー ベンゾジアゼピノン類
CA2130754C (en) * 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
WO1995009160A1 (fr) * 1993-09-30 1995-04-06 Shionogi & Co., Ltd. Derive de benzolactame
IT1297090B1 (it) * 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
DE19920955C2 (de) * 1999-05-06 2002-11-28 Wacker Chemie Gmbh 2-(Benz-)Imidazol-,2-(Benz-)Oxazol- und 2-(Benz-)Thiazol-substituierte Silane und Verfahren zu deren Herstellung
US7582624B2 (en) 2002-09-20 2009-09-01 Arrow Therapeutics Limited Benzodiazepine derivatives and pharmaceutical compositions containing them
CA2529227A1 (en) * 2003-06-26 2005-01-06 Merck & Co., Inc. Benzodiazepine cgrp receptor antagonists
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
EP1928465A1 (en) 2005-09-19 2008-06-11 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
CN101415681A (zh) 2006-03-29 2009-04-22 弗·哈夫曼-拉罗切有限公司 作为mGluR2拮抗剂的吡啶和嘧啶衍生物
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
BR112016017781A2 (pt) * 2014-02-14 2017-08-08 Inception 2 Inc Compostos de pirazolona e usos dos mesmos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131733C (xx) * 1961-06-20
IE903879A1 (en) * 1989-10-30 1991-05-08 Hoffmann La Roche Use of a benzodiazepine and a phenylpyrrylketone derivative

Also Published As

Publication number Publication date
FI915915A (fi) 1992-06-18
HUT59920A (en) 1992-07-28
HU913960D0 (en) 1992-02-28
YU194691A (sh) 1994-01-20
MX9102580A (es) 1992-06-01
IE914369A1 (en) 1992-06-17
PT99821A (pt) 1992-12-31
CS381891A3 (en) 1992-07-15
CN1062528A (zh) 1992-07-08
CA2057646A1 (en) 1992-06-18
EP0491218A1 (en) 1992-06-24
IS3792A7 (is) 1992-06-18
IL100364A0 (en) 1992-09-06
BR9105406A (pt) 1992-08-25
ZA919850B (en) 1992-08-26
KR920012070A (ko) 1992-07-25
AU8974191A (en) 1992-06-18
NO914968D0 (no) 1991-12-16
JPH04275287A (ja) 1992-09-30
FI915915A0 (fi) 1991-12-16

Similar Documents

Publication Publication Date Title
ATA150090A (de) Hoergeraet
DK0439279T3 (da) Borerørs-/foringsbeskyttelsesorgan
NO179545B (no) Konstruksjonsleketöysystem
FI930878A0 (fi) A-substituerade tryptofan-dipeptoidderivat
FI923848A (fi) Utbytbart verktygsskaft
NO914968L (no) Benzodiazepinoner
FI925033A (fi) Foerbaettrade bitumenemulsioner
FI915674A (fi) Kalliopultituslaite
FI931911A (fi) Passageoevervakningsanordning
DK174891A (da) Benzodiazepinderivater
ATA210290A (de) Lotpille
FI923773A (fi) Vaotsugare
FI932807A0 (fi) Braensleelement foer kaernreaktor
SE9101718L (sv) El-box
NO176007C (no) Kantfölgeaggregat
BR9101437A (pt) Copoliester
ATA237490A (de) Rinnenstein
DK124790A (da) Virelaas
KR910014306U (ko) 소화전
SE9002323D0 (sv) Vaermeanordning
FI930896A (fi) Ensilagetillsats
FI932980A (fi) Fasthaollningsdon
SE9000947D0 (sv) Spaerranordning
SE9003880D0 (sv) Transportoer
SE9001656D0 (sv) Mjoelkningsanlaeggning